Navigation Links
Update on pluripotent stem cells (hESC and iPS)
Date:1/15/2010

ESHRE invites you to attend its workshop on 'Update on pluripotent stem cells (hESC and iPS)' followed by a hands on course on 'Derivation and culture of pluripotent stem cells'. The objective of the course on 8 February is to provide participants with an update on the state of the art of pluripotent stem cells. The objective of the hands on workshop during the following days 9-12 February is to provide the participants with the methodology in use for derivation, culture and characterization of pluripotent stem cells.

You are welcome to register for the workshop alone without the hands on course or for both events together. More information on this event can be found on the ESHRE website: http://www.eshre.com/ESHRE/English/Calendar/Eshre-campus/Update-on-pluripotent-stem-cells/page.aspx/854

Here a few of the highlights that will be presented during the course:

  • hESC derivation
  • Freezing and thawing of pluripotent stem cells
  • Spermatogonial and ovarian stem cells
  • Cell reprogramming
  • Genetic stability of pluripotent stem cells
  • Culture of hESC and MSC
  • Registries and stem cell banks
  • Stem cell replacement therapy
  • Ethical aspects

The hands on course will focus on methodologies in:

  • Embryo culture preparation
  • Blastomere biopsy
  • Freezing and thawing
  • Use of extracellular matrices
  • Expansion
  • Characterization
  • Differentiation
  • Reprogramming

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month brings announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies often sparking a heated debate amo
'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
32-022-690-969
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2

Related biology news :

1. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
2. Genome update defines landscape of breast and colon cancers
3. Latest Integrated Microbial Genomes data management system update release
4. National Zoo giant panda pregnancy update
5. Biochemistry of human physiology in health and disease is focus of updated clinical text
6. Beckman Coulter Updates 2008 Outlook
7. US science education organization updates analysis
8. Updated formula measures kidney function more accurately
9. ADA releases updated position statement on functional foods
10. Report updates guidelines on how much weight women should gain during pregnancy
11. ADA releases updated position paper on vegetarian diets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... the family of bacteria that causes whooping cough ... surprising findings about the bacteria,s origin and evolution. ... to control this respiratory disease, which kills 195,000 ... 343 strains of the Bordetella pertussis ... last 100 years illustrates how vaccination has shaped ...
(Date:4/23/2014)... new study by a University of Exeter researcher has ... of wild camels thriving in Australia,s remote outback have ... scale. , Sarah Crowley, of the Environment and Sustainability ... the history of the camel in Australia, from their ... to their current status as unwelcome "invader." , The ...
(Date:4/23/2014)... many social mammals, ravens form different types of social ... and they also form strict dominance relations. From a ... a key ability in daily social life ("knowing who ... group members have with each other sets the stage ... results of this study have been published in the ...
Breaking Biology News(10 mins):Impact of whooping cough vaccination revealed 2How Australia got the hump with 1 million feral camels 2How Australia got the hump with 1 million feral camels 3Ravens understand the relations among others 2
... peak in sight fitness peak, that is for ... Lenski, MSU Hannah Distinguished Professor of Microbiology and Molecular Genetics, ... generating more than 50,000 generations. In a paper published in ... author and MSU graduate student in Lenski,s lab, compares it ...
... genetic signature of respiratory syncytial virus (RSV), the leading cause ... key step toward a better understanding of the immune response ... and a tool that could allow physicians to determine the ... from a team at The Research Institute at Nationwide Children,s ...
... may be more able to cope with dry conditions ... and Colorado State University used a computer model to ... the Amazon rainforest may be more able to withstand ... climate models. Many climate models over predict the ...
Cached Biology News:No peak in sight for evolving bacteria 2Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide 2Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide 3Amazon rainforest more able to withstand drought than previously thought 2
(Date:1/15/2014)... Village, Calif. (PRWEB) January 15, 2014 ... treatment and management through the genomic analysis of tumor ... offer Therapy Finder™, a web-based cancer decision support application ... reporting option with Cynvenio’s ClearID™ genomic test, Therapy Finder ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 DTS Language ... its Online Web Portal for Life Science organizations who need ... specify the subject matter of their documents in advance with ... help reduce time-to-delivery of translations, often a critical factor in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... HARBIN, China, April 23 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced that it,obtained approvals from the State Food ... Geranium ointment and Musk liniment for pain relief. , ...
... China and LOS ANGELES, April 23 /PRNewswire-Asia-FirstCall/ --, - Fourth ... Income was $0.9 Million and Diluted EPS of $.03, ... - 2008 Gross Profit Margin Improved 340 Basis Points to 20.1%, ... EPS of, $0.13, - 2008 ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the ... and internationally, which recently announced it has decreased long-term ... has eliminated another $817,000 of long-term debt. "The remaining ...
Cached Biology Technology:China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief 2China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11Cord Blood America Further Reduction, $817,000, in Long-Term Debt 2
...
... with the xPONENT Software Interface is ... assays using Upstate's Beadlyte® reagents. This ... friendly xPONENT software developed by Luminex. ... for commercial or home-made multiplex kits. ...
... turntable. Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute ... RS-232 port. ... ... ...
Vybrant® Multidrug Resistance Assay Kit...
Biology Products: